abstract |
The invention relates to substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines and to methods for the production thereof, and also to the use thereof for the production of pharmaceuticals for the treatment and/or prophylaxis of diseases; in particular of hematologic diseases, preferably of leucopenia and neutropenia. Formula (I) in which A stands for a group of formula (II), (III), (IV), (V) or (VI) wherein #1 means the binding site for the heterocycle substituted with R1, #2 means the binding site of the carbon atom to which R13 is bonded, #3 means the binding site of the carbon atom to which R4 is bonded. |